New hope for HIV patients: experimental drug shows promise in small trial
NCT ID NCT03902522
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study tested an experimental drug called PRO 140 in 6 adults with HIV whose current medications were no longer controlling the virus. The goal was to see if adding PRO 140 could lower the amount of HIV in their blood. The trial lasted 25 weeks and combined PRO 140 with other HIV drugs to try to improve treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CD02_OpenLabel Investigational Site
Palm Springs, California, 92262, United States
-
CD02_OpenLabel Investigational Site
San Francisco, California, 94115, United States
-
CD02_OpenLabel Investigational Site
New Haven, Connecticut, 06510, United States
-
CD02_OpenLabel Investigational Site
Ft. Pierce, Florida, 34982, United States
-
CD02_OpenLabel Investigational Site
Miami, Florida, 33136, United States
-
CD02_OpenLabel Investigational Site
Miami, Florida, 33139, United States
-
CD02_OpenLabel Investigational Site
Miami, Florida, 33169, United States
-
CD02_OpenLabel Investigational Site
Orlando, Florida, 32803, United States
-
CD02_OpenLabel Investigational Site
West Palm Beach, Florida, 33401, United States
-
CD02_OpenLabel Investigational Site
Decatur, Georgia, 30033, United States
-
CD02_OpenLabel Investigational Site
Chicago, Illinois, 60613, United States
-
CD02_OpenLabel Investigational Site
Wichita, Kansas, 67214, United States
-
CD02_OpenLabel Investigational Site
Syracuse, New York, 13210, United States
-
CD02_OpenLabel Investigational Site
Bellaire, Texas, 77301, United States
-
CD02_OpenLabel Investigational Site
Houston, Texas, 77004, United States
-
CD02_OpenLabel Investigational Site
Houston, Texas, 77098, United States
-
CD02_OpenLabel Investigational Site
Spokane, Washington, 99202, United States
Conditions
Explore the condition pages connected to this study.